Metastatic prostate cancer cells are highly sensitive to 3-Bromopyruvic acid (cas 1113-59-3)

Add time:08/13/2019    Source:sciencedirect.com

Aims3-Bromopyruvate (3-BP), an alkylating agent and a glycolytic inhibitor, is a promising anticancer agent, which can be efficient also against multidrug-resistant cancer cells. The aim of this study was to examine how 3-BP affects the survival and mobility of rat (MAT-LyLu and AT-2) and human (DU-145 and PC-3) metastatic prostate cancer cell lines.

We also recommend Trading Suppliers and Manufacturers of Bromopyruvic acid (cas 1113-59-3). Pls Click Website Link as below: cas 1113-59-3 suppliers

Prev:Research paper2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies
Next:Original research articleAnticancer agent 3-Bromopyruvic acid (cas 1113-59-3) forms a conjugate with glutathione)